BDBM463355 N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-oxopyridin-1-::US10781181, Example 36

SMILES Clc1cccc(OCCNC(=O)c2cnn(Cc3ccc(Cn4ccccc4=O)cc3)c2)c1

InChI Key InChIKey=YTKAVTOCDDALCO-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 463355   

TargetPlasma kallikrein(Human)
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM463355(N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-oxopyridin-...)
Affinity DataIC50: 6.10nMAssay Description:Plasma kallikrein inhibitory activity in vitro was determined using standard published methods. Human plasma kallikrein (Protogen) was incubated at 2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
Go to US Patent

TargetKallikrein-1(Human)
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM463355(N-[2-(3-chlorophenoxy)ethyl]-1-({4-[(2-oxopyridin-...)
Affinity DataIC50: 4.00E+4nMAssay Description:KLK1 inhibitory activity in vitro was determined using standard published methods. Human KLK1 (Callbiochem) was incubated at 25° C. with the fluoroge...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
Go to US Patent